Park SA, Sung NJ, Choi BJ, Kim W, Kim SH, Surh YJ. Gremlin-1 augments the oestrogen-related receptor α signalling through EGFR activation: implications for the progression of breast cancer. 2021 Sep;123(6):988-99. doi: 10.1038/s41416-020-0945-0. Jang JH, Kim DH, Surh YJ. Dynamic roles of inflammasomes in inflammatory tumor microenvironment. 2021 Mar 8;5(1):18. doi: 10.1038/s41698-021-00154-7. Jang JH, Kim DH, Lim JM, Lee JW, Jeong SJ, Kim KP, Surh YJ. Breast Cancer Cell-Derived Soluble CD44 Promotes Tumor Progression by Triggering Macrophage IL1β Production. Cancer Res. 2020 Mar 15;80(6):1342-56. doi: 10.1158/0008-5472.CAN-19-2288. Lee EJ, Kim SJ, Hahn YI, Yoon HJ, Han B, Kim K, Lee S, Kim KP, Suh YG, Na HK, Surh YJ (2019) 15-Keto prostaglandin E2 suppresses STAT3 signaling and inhibits breast cancer cell growth and progression. Redox Biol. 2019 May; 23:101175. 101175. doi: 10.1016/j.redox.2019.101175. doi: 10.1016/j.redox.2019.101175. Lee YH, Song NY, Suh J, Kim DH, Kim W, Ann J, Lee J, Baek JH, Na HK, Surh YJ. Curcumin suppresses oncogenicity of human colon cancer cells by covalently modifying the cysteine 67 residue of SIRT1. Cancer Lett. 2018 Sep 1; 431:219-29. doi: 10.1016/j.canlet.2018.05.036. Ngo HKC, Kim DH, Cha YN, Na HK, Surh YJ. Nrf2 mutagenic activation drives hepatocarcinogenesis. Cancer Res. 2017 Sep 15;77(18):4797-808. doi: 10.1158/0008-5472.CAN-16-3538.